Tech Company Financing Transactions
HEPHAISTOS-Pharma Funding Round
Elaia Partners, Angels Santé and Bpifrance participated in a $11 million Seed capital raise for HEPHAISTOS-Pharma. The round was announced on 5/16/2024.
Transaction Overview
Company Name
Announced On
5/16/2024
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Rue Jean Rostand
Orsay, 91400
France
Orsay, 91400
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
A preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers. Immunotherapy has shown impressive results in the past 5 years by treating cancers like never seen before. Unfortunately, success levels are still very low and only 10% of patients can be cured today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Martine Caroff
Chief Executive Officer
Frederic Caroff
Browse more venture capital transactions:
Prev: 5/16/2024: Leya venture capital transaction
Next: 5/16/2024: Phenomix Sciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs